ATE505480T1 - Knochenpolypeptid-1 - Google Patents
Knochenpolypeptid-1Info
- Publication number
- ATE505480T1 ATE505480T1 AT02805460T AT02805460T ATE505480T1 AT E505480 T1 ATE505480 T1 AT E505480T1 AT 02805460 T AT02805460 T AT 02805460T AT 02805460 T AT02805460 T AT 02805460T AT E505480 T1 ATE505480 T1 AT E505480T1
- Authority
- AT
- Austria
- Prior art keywords
- bone
- bone polypeptide
- polypeptide
- cdna
- present
- Prior art date
Links
- 210000000988 bone and bone Anatomy 0.000 title abstract 5
- 239000002299 complementary DNA Substances 0.000 abstract 2
- 241000251539 Vertebrata <Metazoa> Species 0.000 abstract 1
- 230000004221 bone function Effects 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000003907 kidney function Effects 0.000 abstract 1
- 102000039446 nucleic acids Human genes 0.000 abstract 1
- 108020004707 nucleic acids Proteins 0.000 abstract 1
- 150000007523 nucleic acids Chemical class 0.000 abstract 1
- 229920001184 polypeptide Polymers 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 241000701161 unidentified adenovirus Species 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/51—Bone morphogenetic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Toxicology (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Steroid Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US34122401P | 2001-12-20 | 2001-12-20 | |
| PCT/IB2002/005778 WO2003054005A2 (en) | 2001-12-20 | 2002-12-20 | Bone polypeptide-1 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE505480T1 true ATE505480T1 (de) | 2011-04-15 |
Family
ID=23336705
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT02805460T ATE505480T1 (de) | 2001-12-20 | 2002-12-20 | Knochenpolypeptid-1 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US7425531B2 (de) |
| EP (1) | EP1458749B1 (de) |
| AT (1) | ATE505480T1 (de) |
| AU (1) | AU2002356392A1 (de) |
| CA (1) | CA2469972A1 (de) |
| DE (1) | DE60239763D1 (de) |
| WO (1) | WO2003054005A2 (de) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004111234A1 (ja) * | 2003-06-16 | 2004-12-23 | Takeda Pharmaceutical Company Limited | 新規蛋白質 |
| PL2348114T3 (pl) | 2004-04-21 | 2019-08-30 | Alexion Pharmaceuticals, Inc. | Koniugaty do dostarczania do kości i sposób ich wykorzystania do nakierowywania białek na kość |
| EP1750619B1 (de) | 2004-05-25 | 2013-07-24 | Covidien LP | Flexible gefässverschlussvorrichtung |
| US7309589B2 (en) * | 2004-08-20 | 2007-12-18 | Vironix Llc | Sensitive detection of bacteria by improved nested polymerase chain reaction targeting the 16S ribosomal RNA gene and identification of bacterial species by amplicon sequencing |
| JP4761812B2 (ja) * | 2005-04-18 | 2011-08-31 | 武田薬品工業株式会社 | マスクリン受容体およびその用途 |
| US7470668B2 (en) * | 2005-08-24 | 2008-12-30 | Enobia Pharma Inc. | Method of use of specific natriuretic peptide receptor c ligands, transgenic non-human mammals expressing specific natriuretic peptide receptor c antagonists and cells thereof |
| US20110104705A1 (en) | 2006-09-30 | 2011-05-05 | Takeda Pharmaceutical Company Limited | Musclin receptor and use thereof |
| EP2658979B1 (de) | 2010-12-27 | 2018-02-14 | Alexion Pharmaceuticals, Inc. | Zusammensetzungen mit natriuretischen peptiden und verwendungsverfahren dafür |
| US10052366B2 (en) | 2012-05-21 | 2018-08-21 | Alexion Pharmaceuticsl, Inc. | Compositions comprising alkaline phosphatase and/or natriuretic peptide and methods of use thereof |
| US10822596B2 (en) | 2014-07-11 | 2020-11-03 | Alexion Pharmaceuticals, Inc. | Compositions and methods for treating craniosynostosis |
| WO2016090251A1 (en) | 2014-12-05 | 2016-06-09 | Alexion Pharmaceuticals, Inc. | Treating seizure with recombinant alkaline phosphatase |
| US10603361B2 (en) | 2015-01-28 | 2020-03-31 | Alexion Pharmaceuticals, Inc. | Methods of treating a subject with an alkaline phosphatase deficiency |
| AU2016272282A1 (en) | 2015-05-29 | 2018-01-25 | Igisu Co., Ltd. | Cyclic peptide, and medicine, external preparation and cosmetic each containing said cyclic peptide |
| AU2016308624B2 (en) | 2015-08-17 | 2022-06-23 | Alexion Pharmaceuticals, Inc. | Manufacturing of alkaline phosphatases |
| EP3355904A4 (de) | 2015-09-28 | 2019-06-12 | Alexion Pharmaceuticals, Inc. | Identifizierung wirksamer dosierungsschemata für gewebeunspezifische alkalische phosphatase-enzymersatztherapie von hypophosphatasie |
| JP2018533571A (ja) | 2015-10-30 | 2018-11-15 | アレクシオン ファーマシューティカルズ， インコーポレイテッド | 患者の頭蓋縫合早期癒合症を治療するための方法 |
| EP3426286A4 (de) | 2016-03-08 | 2019-12-04 | Alexion Pharmaceuticals, Inc. | Verfahren zur behandlung von hypophosphatasie bei kindern |
| KR20180125979A (ko) | 2016-04-01 | 2018-11-26 | 알렉시온 파마슈티칼스, 인코포레이티드 | 알칼리성 포스파타아제로 근육 약화의 치료 |
| WO2017173395A1 (en) | 2016-04-01 | 2017-10-05 | Alexion Pharmaceuticals, Inc. | Methods for treating hypophosphatasia in adolescents and adults |
| US10988744B2 (en) | 2016-06-06 | 2021-04-27 | Alexion Pharmaceuticals, Inc. | Method of producing alkaline phosphatase |
| JP7018933B2 (ja) | 2016-08-18 | 2022-02-14 | アレクシオン ファーマシューティカルズ， インコーポレイテッド | 気管気管支軟化症の治療方法 |
| US20180194824A1 (en) | 2016-12-14 | 2018-07-12 | University Of Iowa Research Foundation | Musclin peptides and methods of use thereof |
| MX2019011508A (es) | 2017-03-31 | 2019-11-01 | Alexion Pharma Inc | Metodos para tratar la hipofosfatasia (hpp) en adultos y adolescentes. |
| US11065136B2 (en) | 2018-02-08 | 2021-07-20 | Covidien Lp | Vascular expandable devices |
| US11065009B2 (en) | 2018-02-08 | 2021-07-20 | Covidien Lp | Vascular expandable devices |
| US11913039B2 (en) | 2018-03-30 | 2024-02-27 | Alexion Pharmaceuticals, Inc. | Method for producing recombinant alkaline phosphatase |
| JP7820148B2 (ja) | 2018-08-10 | 2026-02-25 | アレクシオン ファーマシューティカルズ， インコーポレイテッド | アルカリホスファターゼを用いて神経線維腫症１型および関連状態を治療する方法 |
| MX2022007114A (es) | 2019-12-09 | 2022-07-11 | Alexion Pharma Inc | Polipeptidos de fosfatasa alcalina y metodos de uso de los mismos. |
| MX2023002673A (es) | 2020-09-04 | 2023-05-12 | Alexion Pharma Inc | Métodos para el tratamiento de trastornos de mineralización ósea. |
| EP4291224A4 (de) | 2021-02-12 | 2025-01-01 | Alexion Pharmaceuticals, Inc. | Alkalische phosphatasepolypeptide und verfahren zur verwendung davon |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004111234A1 (ja) | 2003-06-16 | 2004-12-23 | Takeda Pharmaceutical Company Limited | 新規蛋白質 |
| US7470668B2 (en) * | 2005-08-24 | 2008-12-30 | Enobia Pharma Inc. | Method of use of specific natriuretic peptide receptor c ligands, transgenic non-human mammals expressing specific natriuretic peptide receptor c antagonists and cells thereof |
-
2002
- 2002-12-20 US US10/499,762 patent/US7425531B2/en not_active Expired - Fee Related
- 2002-12-20 US US10/327,514 patent/US20030125258A1/en not_active Abandoned
- 2002-12-20 AU AU2002356392A patent/AU2002356392A1/en not_active Abandoned
- 2002-12-20 DE DE60239763T patent/DE60239763D1/de not_active Expired - Lifetime
- 2002-12-20 AT AT02805460T patent/ATE505480T1/de not_active IP Right Cessation
- 2002-12-20 CA CA002469972A patent/CA2469972A1/en not_active Abandoned
- 2002-12-20 WO PCT/IB2002/005778 patent/WO2003054005A2/en not_active Ceased
- 2002-12-20 EP EP02805460A patent/EP1458749B1/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| WO2003054005A2 (en) | 2003-07-03 |
| AU2002356392A1 (en) | 2003-07-09 |
| US7425531B2 (en) | 2008-09-16 |
| EP1458749A2 (de) | 2004-09-22 |
| DE60239763D1 (de) | 2011-05-26 |
| CA2469972A1 (en) | 2003-07-03 |
| AU2002356392A8 (en) | 2003-07-09 |
| EP1458749B1 (de) | 2011-04-13 |
| US20050143562A1 (en) | 2005-06-30 |
| US20030125258A1 (en) | 2003-07-03 |
| WO2003054005A3 (en) | 2003-10-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60239763D1 (de) | Knochenpolypeptid-1 | |
| EA200400312A1 (ru) | АНТАГОНИСТИЧЕСКИЕ АНТИТЕЛА ПРОТИВ hTNFSF13b ЧЕЛОВЕКА | |
| ATE382053T1 (de) | System zur antikörperexpression und- synthese | |
| DK1240325T3 (da) | IL-17 og IL-17R homologe polypeptider og terapeutisk anvendelse deraf | |
| MX362028B (es) | Polipeptidos recombinantes extendidos y composiciones que comprenden los mismos. | |
| AR033978A1 (es) | Molecula de anticuerpo con especificidad para factor de necrosis tumoral alfa humano y usos de las mismas | |
| NZ603348A (en) | Simian adenovirus nucleic acid- and amino acid-sequences, vectors containing same, and uses thereof | |
| DK1368060T3 (da) | HMGB1-proteininhibitorer og/eller antagonister til behandlingen af vaskulære sygdomme | |
| MXPA05011085A (es) | Composiciones y metodos relacionados a stop-1. | |
| ATE477272T1 (de) | Verwendung von stefin a als gerüstprotein | |
| PT1290160E (pt) | Polipeptideos pellino humanos | |
| DE60235985D1 (de) | Ntb-a, ein oberflächenmolekül impliziert in der aktivität natürlicher killerzellen (nk) | |
| WO1998011234A3 (en) | Human protein kinases | |
| DE60039677D1 (de) | Akt-3 nukleinsäure, polypeptide und deren verwendung | |
| NO972063D0 (no) | cDNA som koder for en BMP type II reseptor | |
| EA200501711A1 (ru) | Семейство секретируемых белков | |
| SG161106A1 (en) | Inhibitor proteins of a protease and use thereof | |
| WO2003087840A3 (en) | Protein involved in cancer | |
| WO2003057708A3 (en) | Fusion proteins | |
| WO2003059281A3 (en) | Novel variants of rankl protein | |
| EA200971092A1 (ru) | Vegf-d мутанты и их применение | |
| DE69737561D1 (de) | Klonierte rezeptoren des glukagon-ähnlichen peptids-2 | |
| WO2004053052A3 (en) | HUMAN RECOMBINANT ENDOOLIGOPEPTIDASE A (hEOPA) | |
| WO2003036264A3 (en) | Treating diseases mediated by metalloprotease-shed proteins | |
| FR2813606B1 (fr) | Proteine bard1 tronquee, et ses applications diagnostiques et therapeutiques |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |